| Literature DB >> 35445896 |
Reena M Ghosh1, Matthew A Jolley2,3, Christopher E Mascio4,5, Jonathan M Chen4, Stephanie Fuller4, Jonathan J Rome2, Elizabeth Silvestro6, Kevin K Whitehead2.
Abstract
BACKGROUND: Surgical and catheter-based interventions for congenital heart disease require precise understanding of complex anatomy. The use of three-dimensional (3D) printing and virtual reality to enhance visuospatial understanding has been well documented, but integration of these methods into routine clinical practice has not been well described. We review the growth and development of a clinical 3D modeling service to inform procedural planning within a high-volume pediatric heart center.Entities:
Keywords: 3D printing; Cardiac catheterization; Cardiothoracic surgery; Computer aided design; Congenital heart disease; Imaging; Magnetic resonance imaging; Pediatric cardiology; Surgical planning; Virtual reality
Year: 2022 PMID: 35445896 PMCID: PMC9027072 DOI: 10.1186/s41205-022-00137-9
Source DB: PubMed Journal: 3D Print Med ISSN: 2365-6271
Fig. 1Case Selection for Clinical 3D Modeling
Fig. 23D Visualization Modalities. a) 3D printed model; b) Digital model viewed using a 3D PDF; c) Virtual Reality; d) CAD modeling of digital repairs. 3D = Three-dimensional; PDF = portable document file; CAD = computer aided design
Fig. 3Dedicated 3D Imaging Review Suite. Depiction of the 8′ × 15′ 3D Imaging Review Suite, with dedicated space for reviewing patient anatomy in digital formats, printed models and in virtual reality
Fig. 4Number of 3D Modeling Cases Compared to Surgical Case Volume. 3D = Three-dimensional; STAT = The Society of Thoracic Surgeons and The European Association for Cardio-Thoracic Surgery; CPB = cardiopulmonary bypass
Fig. 5Origin of 3D Modeling Request
Description of clinical 3D modeling cohort
| Agea at request (years) | Cross-sectional imaging modality | |
|---|---|---|
| All patients ( | 2.4 (0.85, 6.1) | 19% CTA / 81% CMR |
| 0.72 (0.44, 1.6) | 13% CTA / 87% CMR | |
| 6.2 (2.5, 16.4) | 5% CTA / 95% CMR | |
| 1.3 (0.77, 2.6) | 9% CTA / 91% CMR | |
| 0.45 (0.30, 0.84) | 100% CTA | |
| 2.7 (2.2, 4.1) | 100% CMR | |
| 7.1 (3.0, 11.3) | 50% CTA / 50% CMR | |
| 2.1 (0.8, 5.5) | 17% CTA / 83% CMR | |
| 12.4 (7.2, 14.0) | 100% CMR |
3D Three-dimensional, CTA computed tomography angiography, CMR cardiac magnetic resonance imaging, VSD ventricular septal defect, VAD ventricular assist device, Inn Vein Innominate Vein
aAge presented as median and interquartile range
Anatomic or procedural indication for modeling request according to year
| Indication for modeling | 2018 | 2019 | 2020 |
|---|---|---|---|
| 2 (13%) | 13 (38%) | 15 (32%) | |
| 0 | 7 (21%) | 3 (6%) | |
| 1 (7%) | 3 (9%) | 7 (15%) | |
| 5 (33%) | 6 (18%) | 8 (17%) | |
| 5 (33%) | 0 | 3 (6%) | |
| 0 | 1 (3%) | 5 (11%) | |
| 2 (13%) | 3 (9%) | 1 (2%) | |
| 0 | 1 (3%) | 5 (11%) |
Results expressed as count (percentage)
VSD ventricular septal defect, VAD ventricular assist device
aRefers to unifocalization of aortopulmonary collaterals
Number of prospective and retrospective cases according to year
| Prospective | Retrospective | |
|---|---|---|
| 0 | 15 | |
| 15 | 19 | |
| 17 | 30 |
Fig. 6Utilization of 3D Visualization Modalities By Year. 3D = Three-dimensional; PDF = portable document file; CAD = computer-aided design